Status:
RECRUITING
This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Order to Evaluate the Need of Adjuvant Uric Acid Lowering Therapy
Lead Sponsor:
Sohag University
Conditions:
Hemodialysis
Hyperuricemia
Eligibility:
All Genders
18+ years
Brief Summary
Background: Uricemia dramatically rises with the stage of chronic kidney disease (CKD) and correlates with its mortality. Hemodialysis (HD) being the most used treatment at the end stage kidney diseas...
Detailed Description
Aim of the the work The aim of this study is to estimate the efficacy of Hemodialysis alone for uric acid clearance in patients on hemodialysis. In order to evaluate the need of adjuvant uric acid low...
Eligibility Criteria
Inclusion
- We included all consenting adults aged 18 or older, on maintenance hemodialysis for at least 3 consecutive months receiving 2 to 3 sessions weekly
Exclusion
- Patients aged \< 18 years old .
- Patients on recent hemodialysis less than 3 months.
- We excluded patients who were on Uric acid lowering therapy (UALT).
- Patients received less than 4 hours of hemodialysis and those who had emergency dialysis.
Key Trial Info
Start Date :
July 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07144332
Start Date
July 13 2025
End Date
February 1 2026
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university faculty of medicine
Sohag, Egypt